Janus Henderson Group plc 13D and 13G filings for Collegium Pharmaceutical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 10:36 am Sale |
2022-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
JANUS HENDERSON GROUP PLC JHG |
1,481,170 4.400% |
-506,325 (-25.48%) |
Filing |
| 2022-09-12 08:25 am Sale |
2022-08-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
JANUS HENDERSON GROUP PLC JHG |
1,987,495 5.800% |
-1,786,808 (-47.34%) |
Filing |
| 2022-02-10 3:21 pm Sale |
2021-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
JANUS HENDERSON GROUP PLC JHG |
3,774,303 10.900% |
-1,313,206 (-25.81%) |
Filing |
| 2021-02-11 4:36 pm Purchase |
2020-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
JANUS HENDERSON GROUP PLC JHG |
5,087,509 14.700% |
585,160 (+13.00%) |
Filing |